Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. | Front Genet | 2022 | 36118880 | PubTator, text mining | PubMed |
| The role of long noncoding RNAs as regulators of the epithelial-Mesenchymal transition process in oral squamous cell carcinoma cells. | Front Mol Biosci | 2022 | 36106022 | PubTator, text mining | PubMed |
| miR-22-3p as a potential biomarker for coronary artery disease based on integrated bioinformatics analysis. | Front Genet | 2022 | 36105099 | PubTator, text mining | PubMed |
| TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities. | Trends Cancer | 2022 | 36096997 | PubTator, text mining | PubMed |
| Nonalcoholic Fatty Liver Hepatocyte-Derived lncRNA MALAT1 Aggravates Pancreatic Cell Inflammation via the Inhibition of Autophagy by Upregulating YAP. | Comput Intell Neurosci | 2022 | 36093484 | PubTator, text mining | PubMed |
| Pancancer analysis of a potential gene mutation model in the prediction of immunotherapy outcomes. | Front Genet | 2022 | 36092890 | PubTator, text mining | PubMed |
| The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response. | Front Physiol | 2022 | 36091384 | PubTator, text mining | PubMed |
| P130cas-FAK interaction is essential for YAP-mediated radioresistance of non-small cell lung cancer. | Cell Death Dis | 2022 | 36088346 | PubTator, text mining | PubMed |
| KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player. | Cancers (Basel) | 2022 | 36077838 | PubTator, text mining | PubMed |
| Hsa_circ_0044301 Regulates Gastric Cancer Cell's Proliferation, Migration, and Invasion by Modulating the Hsa-miR-188-5p/DAXX Axis and MAPK Pathway. | Cancers (Basel) | 2022 | 36077718 | PubTator, text mining | PubMed |
| Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells. | Int J Mol Sci | 2022 | 36077517 | PubTator, text mining | PubMed |
| Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes. | Int J Mol Sci | 2022 | 36077416 | PubTator, text mining | PubMed |
| YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation. | Stem Cell Res Ther | 2022 | 36076260 | PubTator, text mining | PubMed |
| Extracellular microRNA and cognitive function in a prospective cohort of older men: The Veterans Affairs Normative Aging Study. | Aging (Albany NY) | 2022 | 36069796 | PubTator, text mining | PubMed |
| Non-coding RNAs to regulate cardiomyocyte proliferation: A new trend in therapeutic cardiac regeneration. | Front Cardiovasc Med | 2022 | 36061542 | PubTator, text mining | PubMed |
| Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer. | Front Genet | 2022 | 36061170 | PubTator, text mining | PubMed |
| Role of released mitochondrial DNA in acute lung injury. | Front Immunol | 2022 | 36059472 | PubTator, text mining | PubMed |
| N-(3,4-dimethoxyphenethyl)-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine inhibits bladder cancer progression by suppressing YAP1/TAZ. | Genes Cells | 2022 | 36054428 | PubTator, text mining | PubMed |
| Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers. | Cell Rep | 2022 | 36044856 | PubTator, text mining | PubMed |
| Posttranslational control of lipogenesis in the tumor microenvironment. | J Hematol Oncol | 2022 | 36038892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=35